Nuzenio

Nasus Pharma

Nasus Pharma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Number of employees of Nasus Pharma Ltd. – AMEX:NSRX - TradingViewTradingView · Sun, 09 Aug 2026 06:30:32 GMTNasus Pharma (NSRX) Stock Forecast and Price Target 2026 - MarketBeatMarketBeat · Sat, 08 Aug 2026 21:34:17 GMTNasus Pharma (NSRX) Advances 1.81%: Testing Key Resistance at $3.55 - Protective Put - dars.gov.etdars.gov.et · Thu, 06 Aug 2026 19:44:10 GMTLegend CEO departs without successor in place—Chutes & Ladders - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 12:29:45 GMTNasus Pharma (NSRX) CEO Dan Teleman resigns as CEO and director - Stock TitanStock Titan · Wed, 29 Jul 2026 21:00:38 GMTNasus Pharma Ltd (NSRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Mon, 27 Jul 2026 18:18:35 GMTNasus Pharma Ltd (NSRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKeyTradingKey · Mon, 27 Jul 2026 09:36:28 GMTNSRX|Nasus Pharma Ltd|Price:3.030|Chg%:+0.020 - TradingKeyTradingKey · Mon, 27 Jul 2026 00:49:45 GMT

Timeline

Sun, 09 Aug 2026 06:30:32 GMTNumber of employees of Nasus Pharma Ltd. – AMEX:NSRX - TradingView
Sat, 08 Aug 2026 21:34:17 GMTNasus Pharma (NSRX) Stock Forecast and Price Target 2026 - MarketBeat
Thu, 06 Aug 2026 19:44:10 GMTNasus Pharma (NSRX) Advances 1.81%: Testing Key Resistance at $3.55 - Protective Put - dars.gov.et
Fri, 31 Jul 2026 12:29:45 GMTLegend CEO departs without successor in place—Chutes & Ladders - Fierce Biotech
Wed, 29 Jul 2026 21:00:38 GMTNasus Pharma (NSRX) CEO Dan Teleman resigns as CEO and director - Stock Titan
Mon, 27 Jul 2026 18:18:35 GMTNasus Pharma Ltd (NSRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Nasus Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.